DealShare Was Worth $1.7 Billion. What Happened?

DealShare is one of the clearest examples of how quickly the Indian startup market can change its view of a business.

In February 2022, the company was valued at around $1.7 billion after raising $45 million from a subsidiary of the Abu Dhabi Investment Authority. DealShare had raised roughly $393 million in total and had positioned itself as a major player in India's emerging value-commerce market.

Four years later, the picture is radically different. DealShare is reportedly in advanced talks to be acquired by online pharmacy Truemeds in a share-swap transaction that would value the company at only a little over its reported $90 million cash balance.

That would represent roughly a 95% decline from its peak valuation.

But the valuation collapse is only the headline. The more useful question is what happened to the underlying business.

The Original DealShare Thesis Was Strong

DealShare was founded in 2018 by Vineet Rao, Sourjyendu Medda, Sankar Bora and Rajat Shikhar. Its initial strategy was built around a relatively simple observation: India's next wave of online consumers would not necessarily look like the customers Amazon and Flipkart were targeting.

The company focused on price-conscious consumers in Tier-II and Tier-III cities and offered a curated selection of everyday products at low prices. Instead of relying entirely on conventional digital advertising, DealShare used a community-driven model where customers could share deals and help aggregate demand.

By early 2022, DealShare said it had more than 10 million customers across more than 100 cities in 10 states. Management was targeting a much larger market of new-to-internet and value-seeking consumers.

On paper, the model had several attractive characteristics:

• Low-priced products
• Focus on smaller cities
• Local and lesser-known brands
• Community-led customer acquisition
• Demand aggregation
• Private-label potential
• A relatively narrow product assortment compared with large marketplaces

This was not an irrational business model. In fact, the early economics were compelling enough to attract some of India's biggest technology investors.

Why Investors Valued DealShare at $1.7 Billion

The important thing to understand about the 2022 valuation is that investors were not paying $1.7 billion for the business DealShare had already built. They were paying for what they expected that business to become.

In 2021, DealShare raised $144 million at a valuation of approximately $455 million. Within months, its valuation had increased to around $1.7 billion following its Series E financing.

The investment thesis was essentially a scale argument.

If DealShare could acquire millions of value-conscious consumers cheaply, replicate the model across hundreds of cities and build its own supply and private-label ecosystem, the company could potentially become a major Indian commerce platform.

Management was making extremely aggressive projections. In February 2022, the company said it was approaching a $1 billion gross revenue run rate and expected to reach a $3 billion gross revenue run rate within the following year while targeting operational profitability.

That expectation is important because it explains the valuation better than simply saying “investors overvalued the startup.”

The valuation was essentially pricing in a future DealShare that had not yet been proven.

The Problem With Scaling the Model

DealShare's biggest challenge was not whether Indian consumers wanted cheaper products. They clearly did.

The problem was whether the company could preserve its economic advantage as it became larger.

At an early stage, a focused assortment, local sourcing and community-driven demand can create an attractive operating model. But national expansion introduces a different set of problems.

More cities mean more inventory complexity. More warehouses mean more fixed costs. More customers mean greater working-capital requirements. And competing for those customers means higher pressure on pricing, delivery and retention.

The business therefore moved from a relatively simple proposition into a much more complicated retail operation.

The B2B Expansion Became a Major Turning Point

DealShare later expanded into B2B, selling products to retailers and kiranas.

The strategic logic was understandable. DealShare already had sourcing capabilities, supplier relationships and logistics infrastructure. B2B could potentially increase volumes and improve utilisation of that infrastructure.

But B2B distribution is a difficult market. Traditional FMCG distribution in India already has deep retailer relationships, established logistics and highly competitive economics.

DealShare eventually shut its B2B business in September 2023. The company also laid off employees as part of the restructuring. Contemporary reports said the B2B operation represented roughly 20–30% of revenue at the time.

This decision had a major financial consequence: DealShare became a substantially smaller business almost overnight.

The Revenue Collapse Tells the Real Story

The most revealing numbers are not the valuation numbers. They are the revenue numbers.

DealShare's operating revenue increased slightly in FY23, but then fell approximately 75% in FY24 following the restructuring and B2B shutdown.

FY25 showed some stabilisation, but revenue remained far below the FY23 level while the company continued to report a loss. Inc42's financial data puts FY25 revenue at approximately ₹523.5 crore and the net loss at roughly ₹87.7 crore.

This is the more important diagnosis: DealShare managed to reduce its losses, but it did not recover its growth.

Cost Cutting Worked — But It Created a Smaller Company

There is a temptation to look at the decline in losses and conclude that the turnaround was working.

There is some truth to that.

DealShare reduced total expenses dramatically. In FY24, expenses fell by around 70% to ₹768 crore from approximately ₹2,558 crore in FY23. Employee costs also fell substantially.

But there is a difference between reducing burn and building a profitable growth engine.

DealShare achieved the first. The second remained unproven.

The company effectively exchanged scale for survival.

The Founder Exits Were Another Signal

The restructuring was not limited to the financial statements.

Three of the four co-founders left the company during the restructuring period. Vineet Rao stepped down as CEO in 2023, Sankar Bora also left, and Sourjyendu Medda later exited his operational role. Kamaldeep Singh, a former Big Bazaar executive, became CEO.

The final co-founder, Rajat Shikhar, subsequently left the company in 2025, according to recent reporting.

Founder exits do not automatically mean that a startup is failing. But when they happen alongside a business-model change, layoffs, geographic consolidation and the closure of a major business vertical, they become a strong indicator that the original strategy has been substantially reset.

DealShare Was Also Caught Between Different Ecommerce Models

The Indian ecommerce market changed significantly while DealShare was restructuring.

Traditional marketplaces continued to dominate large-scale selection. Meesho became a major force in value-oriented ecommerce. Quick-commerce companies changed consumer expectations around delivery speed.

That created a difficult competitive environment.

DealShare's original proposition was built around value. But consumers increasingly expected value combined with convenience, availability and speed.

That is a much harder proposition to deliver profitably.

The Omnichannel Pivot

DealShare subsequently began moving toward an omnichannel model, combining online commerce with local and regional supply, private labels and faster delivery.

In its later B2C strategy, the company focused on an aspiring middle-class customer and relaunched operations around local suppliers, regional brands and two-hour delivery in selected markets including Jaipur, Lucknow, Kolkata and parts of NCR.

Strategically, the move made sense.

The problem was timing.

By then, DealShare had already gone through a major restructuring and had lost a significant amount of scale. It was attempting to rebuild the business while operating in an increasingly competitive ecommerce environment.

So Was DealShare a Bad Business?

Not necessarily.

The better conclusion is that DealShare had a good initial market insight but struggled to turn that insight into a durable competitive advantage at scale.

The insight was simple: millions of Indian consumers wanted affordable products and were becoming comfortable with online shopping.

That insight was correct.

The difficult part was monetising it.

Low prices are easy for competitors to understand. Social commerce can be copied. Local sourcing can be replicated. Private labels can be developed by competitors. And customer acquisition advantages tend to weaken as a company moves beyond its initial high-engagement communities.

In other words, DealShare had a strong market thesis, but the evidence for a strong long-term moat was weaker.

The $1.7 Billion Valuation Was Based on a Different Market

DealShare's valuation also has to be viewed in the context of 2021–22.

Indian internet companies were receiving extremely high growth multiples. Capital was readily available, ecommerce adoption was accelerating and investors were willing to underwrite aggressive expansion plans.

The valuation environment changed dramatically afterward.

Investors became more focused on cash generation, contribution margins and the ability to build sustainable businesses without continuously raising capital.

Once the growth assumptions weakened, the valuation multiple could not survive.

This is why a move from $1.7 billion to roughly $90 million should not be interpreted as the company literally losing $1.6 billion of physical economic value.

Most of that number represented the market's previous expectation of future growth.

Why the Truemeds Deal Is So Interesting

The reported Truemeds transaction is potentially the final stage of this reset.

According to Economic Times, Truemeds would issue shares to DealShare's investors at a valuation of around $600 million, while DealShare itself would be valued at slightly above its reported $90 million cash balance.

If completed on those terms, the transaction would effectively say that the market is assigning very little standalone value to DealShare's operating business compared with the value investors once assigned to its growth potential.

There is still strategic value in DealShare's network, sourcing relationships and presence in smaller cities. Truemeds could potentially use some of that infrastructure as it expands its own healthcare distribution network.

That is why an acquisition can make sense even when the standalone business is no longer worth its previous valuation.

The Bigger Lesson for D2C and Ecommerce Founders

DealShare's story is not simply a warning against raising too much money.

The more important lesson is the difference between product-market fit and scalable economics.

A startup can prove that customers want its product without proving that the company can profitably serve those customers at 10x or 100x the current scale.

DealShare appears to have proven the first proposition.

The second became considerably harder.

For D2C and ecommerce companies, the questions investors should ultimately ask are not just:

• How many customers do you have?
• How fast is revenue growing?
• How large is the market?
• How much money can you raise?

The harder questions are:

• Does customer acquisition remain efficient as the company scales?
• Can gross margins support logistics and fulfilment?
• Does the company have pricing power?
• Can competitors copy the model?
• Does growth require disproportionately more working capital?
• Can the business remain profitable without continuous external funding?
• Does the competitive advantage become stronger or weaker as the company gets bigger?

What Actually Went Wrong at DealShare?

The simplest explanation is that DealShare tried to scale several different businesses before establishing a durable economic engine.

It moved from social commerce into B2B, private labels, broader retail and omnichannel operations while the competitive environment was changing.

The B2B business was eventually shut. The geographic footprint was reduced. Hundreds of employees were affected by restructuring. Most of the founding team departed. Revenue collapsed and then stabilised at a much smaller level.

The company did manage to reduce its losses substantially, which shows that the business could be made leaner.

But leaner was not the same as larger.

And that is ultimately the central lesson from DealShare.

DealShare did not prove that Indian consumers did not want value ecommerce. It failed to prove that its particular model could capture that opportunity at the scale implied by a $1.7 billion valuation.

The reported Truemeds transaction, if completed, would be the clearest financial expression of that gap between the opportunity investors once priced in and the business that ultimately emerged.